Phase 3 Corticosteroids Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Hydrocortisone and Fludrocortisone for Critical Illness-related Corticosteroid Insufficiency
Critical Illness Related Corticosteroids Insufficiency
Assistance Publique - Hôpitaux de Paris1,092 enrolled1 locationNCT04404400
Completed
Phase 3
Australasian Antenatal Study To Evaluate the Role Of Intramuscular Dexamethasone versus Betamethasone prior to preterm birth to increase survival free of childhood neurosensory disability – a randomised controlled trial
Long-term childhood neurosensory disability following antenatal corticosteroids given to women at risk of preterm birth at less than 34 weeks gestatation
Women’s and Children’s Hospital, SA1,499 enrolled1 locationACTRN12608000631303
Completed
Phase 3
Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial
Women at risk of preterm birth, at less than 32 weeks gestation, who have already received a course of prenatal corticosteroids.
Professor Caroline Crowther980 enrolled1 locationACTRN12606000318583